Selecciona el artículo para ver su contenido
| Hepatology Highlights | 2,343 visitas |
| Is pre-treatment liver biopsy necessary for all hepatitis C genotypes? | 1,395 visitas |
| Annals Impact Factor 1.67. | 1,305 visitas |
| The role of hepatitis B immunoglobulin in hepatitis B related liver transplantation: | 1,238 visitas |
| Comparison of acoustic radiation force impulse imaging (ARFI) to liver biopsy histologic scores in the evaluation of chronic liver disease: | 1,192 visitas |
| Hepatology Highlights | 1,042 visitas |
| Recurrent idiopathic acute hepatitis-associated aplastic anemia/pancytopenia fourteen years after initial episode | 1,000 visitas |
| First confirmed case of native polyomavirus BK nephropathy in a liver transplant recipient seven years post-transplanterferon a, ribavirin and telaprevir | 970 visitas |
| A Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection | 946 visitas |
| The Annals of Hepatology welcomes the Canadian Association for the Study of the Liver (CASL) | 943 visitas |
| Prevalence and factors associated with the presence of abnormal function liver tests in patients with ulcerative colitis | 939 visitas |
| Efficacy of maintenance subcutaneous hepatitis B immune globulin (HBIG) post-transplant for prophylaxis against hepatitis B recurrence | 935 visitas |
| Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients | 896 visitas |
| Spontaneous clearance of hepatitis C infection post-liver transplant: A rare but real phenomenon? | 886 visitas |
| A review of drug interactions with boceprevir and telaprevir: | 884 visitas |
| Acetylcholine receptor antibody positive generalized Myasthenia gravis in association with Primary Biliary Cirrhosis | 883 visitas |
| Hepatic lymphoma in a post renal transplant patient with chronic hepatitis B | 866 visitas |
| Adult live donor liver transplantation: | 865 visitas |
| Treatment issues surrounding hepatitis C in renal transplantation: | 858 visitas |
| Non-invasive assessment of liver fibrosis using ARFI with pathological correlation, a prospective study | 853 visitas |
| The direct-acting antivirals for hepatitis C virus and the risk for hepatocellular carcinoma | 834 visitas |
| Hepatology Highlights | 795 visitas |
| Primary hepatic neuroendocrine tumour requiring live donor liver transplantation: | 744 visitas |
| Hepatology Highlights | 721 visitas |
| Persistence of virologic response after liver transplant in hepatitis C patients treated with ledipasvir/sofosbuvir plus ribavirin pretransplant | 684 visitas |
| The use of sildenafil to treat portopulmonary hypertension prior to liver transplantation | 681 visitas |
| Hepatology Highlights | 654 visitas |
| A phase 2 study of filibuvir in combination with pegylated IFN alfa and ribavirin for chronic HCV | 637 visitas |
| Hepatology highlights | 630 visitas |
| Antimitochondrial antibody serocoversion post-liver transplant during hepatitis C treatment with peginterferon α, ribavirin and telaprevir | 628 visitas |
| Hepatitis B in pregnancy: | 622 visitas |
| Protease inhibitor-based triple therapy is highly effective for hepatitis C recurrence after liver transplant: | 608 visitas |
| First successful treatment of post-liver transplant hepatitis C fibrosing cholestatic hepatitis with boceprevir, peginterferon and ribavirin in a pre-transplant null responder | 540 visitas |
| Concordance of sustained virologic response at weeks 4, 12 and 24 post-treatment of hepatitis C in the era of new oral direct-acting antivirals: A concise review | 539 visitas |
| Transplanting Kidney Allografts from Hepatitis C Infected Donors into Hepatitis C Uninfected Recipients: | 350 visitas |
Eric M Yoshida
- Originario de:
- Semblanza:
- Enfermedades tratadas:
- Curriculum:
¡Actualice sus datos!
Con el objetivo de difundir los datos actualizados de los autores a los pacientes, amigos, alumnos o colegas te invitamos a proporcionar o confirmar al menos su
nombre, correo y semblanza